Africa falls short of global targets in cutting TB cases and deaths
Tuberculosis deaths in Africa fell by 26 percent between 2015 and 2021, with high-burden TB countries surpassing initial targets to lower TB cases.
Stay updated with breaking news from Tb Consortium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tuberculosis deaths in Africa fell by 26 percent between 2015 and 2021, with high-burden TB countries surpassing initial targets to lower TB cases.
Sade Oguntola Nigeria and six other countries are to benefit from a 250,000 patient courses of short course rifapentine-based preventive treatment
March 24 marks World Tuberculosis (TB) Day. It is important to reflect on the progress we have made in the fight against TB and the opportunities that lie ahead. Over the past few years, breakthroughs in research and development mean that treatment of drug-resistant TB has been shortened from 20 months to 6 months,1 and a pipeline of new treatment options means that some forms of drug-susceptible TB might be treatable with as little as 2 months of therapy.2 Additionally, affordable and accurate molecular diagnostics promise to revolutionise how we detect TB.
The Unitaid-funded IMPAACT4TB Consortium, led by the Aurum Institute, announced today that it will provide 250,000 patient courses of short course rifapentine-based preventive treatment regimens to seven countries to help prevent tuberculosis (TB). The patient courses will include the three-month 3HP regimen, and the even shorter 1HP, that is only…